A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
about
Putative Role of Red Wine Polyphenols against Brain Pathology in Alzheimer's and Parkinson's DiseaseChallenges in Analyzing the Biological Effects of ResveratrolRecent Advances in Neurogenic Small Molecules as Innovative Treatments for Neurodegenerative DiseasesCurcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence?Harnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and ChallengesThe evidence for natural therapeutics as potential anti-scarring agents in burn-related scarringSlowing ageing by design: the rise of NAD(+) and sirtuin-activating compoundsBridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialA genomics approach identifies selective effects of trans-resveratrol in cerebral cortex neuron and glia gene expression.Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.Therapeutic Effects of Phytochemicals and Medicinal Herbs on Depression.The Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell Subsets in Humans.Nutritional and Pharmacological Strategies to Regulate Microglial Polarization in Cognitive Aging and Alzheimer's Disease.Effects of resveratrol on drug- and carcinogen-metabolizing enzymes, implications for cancer prevention.Resveratrol supplementation confers neuroprotection in cortical brain tissue of nonhuman primates fed a high-fat/sucrose diet.Resveratrol attenuates acute kidney injury by inhibiting death receptor‑mediated apoptotic pathways in a cisplatin‑induced rat model.Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease.Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.Impact of Resveratrol on Glucose Control, Hippocampal Structure and Connectivity, and Memory Performance in Patients with Mild Cognitive Impairment.The Immunomodulatory Effects of Plant Extracts and Plant Secondary Metabolites on Chronic Neuroinflammation and Cognitive Aging: A Mechanistic and Empirical Review.Outcomes Assessment in Clinical Trials of Alzheimer's Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs.Resveratrol as a Natural Autophagy Regulator for Prevention and Treatment of Alzheimer's Disease.The NAD+-Dependent Family of Sirtuins in Cerebral Ischemia and Preconditioning.The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials.Oleuropein aglycone and polyphenols from olive mill waste water ameliorate cognitive deficits and neuropathology.Caloric restriction: beneficial effects on brain aging and Alzheimer's disease.Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine.The role of modulation of antioxidant enzyme systems in the treatment of neurodegenerative diseases.Sirtuins as modifiers of Parkinson's disease pathology.Association between high consumption of phytochemical-rich foods and anthropometric measures: a systematic review.Olive polyphenols: new promising agents to combat aging-associated neurodegeneration.Targeting extracellular matrix remodeling in disease: Could resveratrol be a potential candidate?Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends.Health-beneficial nutraceuticals-myth or reality?Vascular inter-regulation of inflammation: molecular and cellular targets for CNS therapy.Could Sirtuin Activities Modify ALS Onset and Progression?Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications.Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids.Targeting neuroinflammation in Alzheimer's disease: evidence for NSAIDs and novel therapeutics.Gene Therapy in the Nervous System: Failures and Successes.
P2860
Q26738450-E27497E5-DAE7-4409-9213-8CA24B370FB0Q26746257-11A51C31-F0AF-4888-B348-BA87786B2CA1Q28069509-D4CF0B3D-CE0F-48AA-8616-66181B926D1FQ28071699-CB371481-7B06-4877-A16C-456A4FF3F8C6Q28072061-7CCFCC78-73BA-40B7-96BF-FB4A34717396Q28077410-1193576F-D45B-4B97-AF3E-7E46C2DDE746Q28314993-D0C4CD35-2C1A-48F2-86B5-72BE6D318BCAQ29994589-6FCFB02B-9D49-45E9-88F6-888EFD2BFE73Q33602768-4AD8B73C-46EE-4395-8D24-C0F54120AF57Q33624653-A567347A-073E-4810-9B6A-2C43F2E40D5CQ33630966-0F6CBE1D-8E16-4A23-8D0B-11DEF46C02A5Q33701615-6DD5C893-191B-4A7D-9900-D2435225F089Q33770234-22E3004D-CA85-49D4-8C6B-FF20EAD7EEE2Q33771427-0B23B6C4-8084-4300-888C-D8F8D2D414CCQ37062478-51810477-5CE1-4E85-8E1B-5047B7AF0DC0Q37297507-B1970101-A4D7-4904-B194-F6E07BFAE875Q37584887-47500B0F-6602-4AC4-B95F-9F3D909B1EE0Q37653312-5741BF51-7924-48E3-97BC-BF3C1A450B0AQ37683181-EF5C5EDE-B1A9-4C32-A148-162CA3DECBE5Q37692206-65724263-363A-4FBB-B791-862252F92D21Q37730520-AF00BA2C-14C0-4A52-9DCF-5D391BA0240BQ38637798-88E0762B-9F5E-40E2-B88A-7EAC6DD04609Q38661899-381DFB9A-3501-4A8F-9643-18054753F627Q38672062-09810DDE-A936-4C02-A6CD-1073617C2587Q38821665-705028F5-B226-40EB-9C17-9DAA25A615EEQ38848268-3BDE4650-D0EB-461F-AB3A-6FFAAA5DA05AQ38872085-CDB63E86-41C2-424F-9F11-B49620D7528BQ38889475-07D413E3-0442-40DC-9234-6499519C2E98Q38893382-BEF86F73-B884-4A8D-B5B4-3D0DBA949E22Q38949627-5BAAA7EC-9BBD-4BFE-83CF-6E72F4F482C6Q38985937-48D6FD0F-83D2-4121-A292-5822850107D1Q38995157-12092CBD-D4A7-4167-890F-CC67E92FDE2EQ39022532-2B87B908-8D87-45C1-888B-AB964F99D8ABQ39030138-39434DDF-736E-45AD-94E4-9F534FA8CB4AQ39031301-B3946493-0ECC-44A5-B6A7-4003A53E9835Q39036105-60F088BA-3CF7-4662-A72E-13A13BE7ED3AQ39170234-DF6E24DE-1677-4DBE-A48C-C0B570641D04Q39249384-B63B7EDF-6B9B-4B3D-8CBB-DD37F72E2AC8Q39689655-EFDEA78D-3A1F-43DF-8A88-C7F5FDE3D647Q40070708-A044FA31-FC38-4346-86FC-A389B0F9A105
P2860
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
@ast
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
@en
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
@nl
type
label
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
@ast
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
@en
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
@nl
prefLabel
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
@ast
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
@en
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
@nl
P2093
P2860
P1433
P1476
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
@en
P2093
Alzheimer's Disease Cooperative Study
Brigid A Reynolds
Christopher H van Dyck
Jacobo Mintzer
James B Brewer
Rema Raman
Robert A Rissman
Ronald G Thomas
Suzanne Craft
P2860
P304
P356
10.1212/WNL.0000000000002035
P407
P577
2015-09-11T00:00:00Z